Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

Patient activation – not just a strategy but a necessity

By Becky Paul

- PMLiVE

BMS and Bain Capital launch new company to develop immunology therapies

The newly formed company has in-licensed five investigational immunology drugs from BMS

EU flag

CHMP recommends BeOne Medicines’ Tevimbra for new lung cancer indication

Non-small cell lung cancer accounts for up to 90% of all lung cancer cases

- PMLiVE

Solving the patient engagement value equation

By Stephen O’Farrell

Biogen Idec building

Biogen’s Qalsody granted MHRA approval to treat rare form of motor neurone disease

Mutations in the SOD1 gene are responsible for approximately 2% of all cases of the disease

- PMLiVE

FDA grants fast track designation to Nektar’s rezpegaldesleukin in alopecia areata

Approximately 700,000 people in the US currently have some form of the autoimmune disease

- PMLiVE

The power of representation, innovation and trust in rare disease clinical trials

By Carol Pitcher-Towner

HCP talking to patients

Designing with patients in mind: How to build more inclusive clinical trials

Discover how patient-centred design transforms inclusive clinical trials. Learn to overcome trial recruitment challenges by listening to patients and creating studies that fit real lives.

Cuttsy + Cuttsy

- PMLiVE

Mastering Patient Recruitment: A Framework of Five Essential Strategies Developed Over 15 Years

Clinical trial patient recruitment and retention practices have significantly advanced over the last 15 years thanks to technological innovations and the rise of AI, shifting patient expectations and the increased,...

Innovative Trials

- PMLiVE

The Impact of AI on Clinical Trials: Four Key Benefits and Three Major Risks

Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by streamlining the drug development process and helping to generate more robust data, which...

Innovative Trials

Three Key Trends Shaping the Future of Clinical Trials

So far this year, we have witnessed several announcements that could have a major impact on the clinical trials market and our global health overall.

Innovative Trials

- PMLiVE

Sanofi’s Sarclisa approved by EC to treat newly diagnosed multiple myeloma

The drug is already approved in the EU across three other multiple myeloma indications

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links